Christian Bekking

Consultation sur une proposition d’approche provisoire visant à ramener à 180 jours le délai d’examen de certains médicaments pédiatriques

Consultation On Proposed Interim Approach To Reduce Review Timeline To 180 Days For Certain Pediatric Drugs

Santé Canada obtient une injonction permanente visant à empêcher Canlab Research de vendre illégalement des peptides injectables

Health Canada Obtains Permanent Injunction To Prevent Illegal Sale Of Injectable Peptides By Canlab Research

La Cour Fédérale Clarifie La Procédure Applicable Aux Requêtes En Jugement Sommaire Et En Procès Sommaire

Federal Court Provides Process Guidance For Summary Judgment Motions And Trials

L'APP lance une voie révisée pour les négociations non complexes concernant le prix de médicaments

PCPA Introducing Revisions To Pathway For Non-complex Drug Negotiations

La Cour d'appel fédérale confirme qu'il n'est pas nécessaire de tenir compte des demandes de brevets déposées avant la présentation abrégée de drogue nouvelle pour un médicament générique, mais inscrites au registre après

Federal Court Of Appeal Confirms Generic Not Required To Address Patent Submitted Before ANDS Filing But Listed After

Federal Court Rules On Patent Listing Again, Confirms Generic Not Required To Address Patent Submitted Before ANDS Filing But Listed After

Canada's Drug Agency Seeks Input On HTA Methods Guide And Also Announces New Coalition To Improve Medication Use

2023-2024 Pan-Canadian Pharmaceutical Alliance Impact Report

Generic Not Required To Address Patent Submitted Before ANDS Filing But Listed After

Health Canada And The Competition Bureau Commit To Information Sharing To Combat False, Misleading Or Deceptive Health Claims

Ontario Ministry Of Health Proposes Regulatory Amendments Removing Submission Requirements For Well-established Drugs

CADTH Time-limited Recommendation Category To Enhance Earlier Access To Promising New Drugs

pCPA Announces New Three-year Pricing Initiative Agreement For Generic Drugs With CGPA, Appointment Of Douglas Clark As Its First CEO

Innovative Medicines Canada Proposes Framework For Innovative Agreements For Drug Reimbursement